PJ Chen currently is senior vice president of APRINOIA Therapeutics responsible for overall portfolio delivery, PI site network, medical and regulatory affairs. Previously, PJ served as president, United Biopharma (UBP) China responsible for clinical development strategy, R&D lab/pilot factory project and company daily operation. Before the assignment to UBP, PJ served as VP, global clinical development at United Neuroscience within UBI group of companies. Prior to that, PJ was executive director at PPD as area head for north Asia clinical management. In this role, he provided overall business and clinical strategy support for clients and clinical management group in China, Hong Kong, Korea and Taiwan. Upon completion of his graduate training at MIT, PJ worked at MGH/HMS/MIT Martinos Center for Biomedical Imaging and was actively involved in biomarker translational research with focus on oncology drug development. After years of working in Boston, PJ returned to Asia and since worked with CRO and Pharma companies with increasing responsibilities.